Alcobra Ltd fka ADHD

[midastouch017]

Alcobra Ltd. to Provide Corporate Overview at the Jefferies 2014 Global Healthcare Conference
Tuesday 27 May 2014

Alcobra Ltd. (Nasdaq:ADHD), an emerging biopharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced that Dr. Yaron Daniely, President and Chief Executive Officer of Alcobra, will provide a corporate overview at the Jefferies 2014 Global Healthcare Conference taking place June 2-5 in New York City.
Jefferies 2014 Global Healthcare Conference Presentation Details
Date: Tuesday, June 3, 2014
Time: 8:00am Eastern
Location: Grand Hyatt Hotel in New York City
Webcast: http://wsw.com/webcast/jeff82/adhd